Central India Institute Of Haematology And Oncology Private Limited
Provides health and social care services, including blood, sperm, and organ banking.
2011 | Nagpur, Maharashtra (India) | Active
Central India Institute Of Haematology And Oncology Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -11.48%
- Profit Growth -38.80%
- Ebitda -36.06%
- Net Worth 5.27%
- Total Assets -17.26%
About Central India Institute Of Haematology And Oncology
Central India Institute Of Haematology And Oncology Private Limited (CIIOHAOPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 May 2011 and has a history of 13 years and nine months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Avinash Pophali and Surekha Pophali serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100MH2011PTC217386
- Company No.
217386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Central India Institute Of Haematology And Oncology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Pophali  | Director | 12-May-2011 | Current |
| Surekha Pophali | Director | 12-May-2011 | Current |
Financial Performance of Central India Institute Of Haematology And Oncology.
Central India Institute Of Haematology And Oncology Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.48% decrease. The company also saw a substantial fall in profitability, with a 38.8% decrease in profit. The company's net worth moved up by a moderate rise of 5.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Central India Institute Of Haematology And Oncology?
In 2021, Central India Institute Of Haematology And Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Central India Institute Of Haematology And Oncology?
Central India Institute Of Haematology And Oncology has a workforce of 21 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Central India Institute Of Haematology And Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Central India Institute Of Haematology And Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
